Frontiers in Oncology | Thoracic Oncology

Systematic Review

Published on 14 Jun 2022

Beyond Crizotinib: A Systematic Review and Meta-Analysis of the Next-Generation ALK Inhibitors as First-Line Treatment for ALK-Translocated Lung Cancer

in Thoracic Oncology

Emilio Francesco Giunta
Alessio Signori
Howard Jack West
Giulio Metro
Alex Friedlaender
Kaushal Parikh
Giuseppe Luigi Banna
Alfredo Addeo

Frontiers in Oncology

doi 10.3389/fonc.2022.921854

7,361 views
6 citations

Systematic Review

Published on 10 Jun 2022

Risk Factors for Brain Metastases in Patients With Small Cell Lung Cancer: A Systematic Review and Meta-Analysis

in Thoracic Oncology

Haiyan Zeng
Danyang Zheng
Willem J. A. Witlox
Antonin Levy
Alberto Traverso
Feng-Ming (Spring) Kong
Ruud Houben
Dirk K. M. De Ruysscher
Lizza E. L. Hendriks

Frontiers in Oncology

doi 10.3389/fonc.2022.889161

6,823 views
15 citations

Original Research

Published on 10 Jun 2022

The Applicability of the Results in the Asian Population of ORIENT-11 to a Western Population According to the ICH-E5 Framework

in Thoracic Oncology

Stephen V. Liu
Misako Nagasaka
Victoria Stefaniak
Kristi Gruver
Yong Lin
David Ferry
Mark A. Socinski
Li Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.859892

8,162 views
3 citations

Original Research

Published on 08 Jun 2022

Plasma CXCL14 as a Candidate Biomarker for the Diagnosis of Lung Cancer

in Thoracic Oncology

Peng-Fei Tian
Yu-Chen Ma
Dong-Sheng Yue
Fan Liang
Chen-Guang Li
Chen Chen
Hua Zhang
Xiao-Yan Sun
Wu-Hao Huang
Zhen-Fa Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.833866

4,637 views
6 citations

Original Research

Published on 08 Jun 2022

Platelet Activation in High D-Dimer Plasma Plays a Role in Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Mutant Lung Adenocarcinoma

in Thoracic Oncology

Meng-Jung Lee
Chih-Ming Weng
Wei Chao
Yueh-Fu Fang
Fu-Tsai Chung
Chien-Huang Lin
Han-Pin Kuo

Frontiers in Oncology

doi 10.3389/fonc.2022.876051

43,450 views
5 citations

Original Research

Published on 08 Jun 2022

A Novel Score Combining Magnetic Resonance Spectroscopy Parameters and Systemic Immune-Inflammation Index Improves Prognosis Prediction in Non-Small Cell Lung Cancer Patients With Brain Metastases After Stereotactic Radiotherapy

in Thoracic Oncology

Dong Guo
Jiafeng Liu
Yanping Li
Qingqing Chen
Yunzheng Zhao
Xinwei Guo
Shuchai Zhu
Shengjun Ji

Frontiers in Oncology

doi 10.3389/fonc.2022.762230

2,820 views
5 citations

Case Report

Published on 08 Jun 2022

Case Report: Exceptional Response to Poziotinib in Patient with Metastatic Non-Small Cell Lung Cancer With EGFR Exon 20 Insertion Mutation

in Thoracic Oncology

Arsela Prelaj
Achille Bottiglieri
Gajanan Bhat
Rocky Washington
Giuseppina Calareso
Gabriella Francesca Greco
Roberto Ferrara
Marta Brambilla
Alessandro De Toma
Mario Occhipinti

Frontiers in Oncology

doi 10.3389/fonc.2022.902967

3,869 views
6 citations

Original Research

Published on 07 Jun 2022

Targeting ALK in Neuroendocrine Tumors of the Lung

in Thoracic Oncology

Dilara Akhoundova
Martina Haberecker
Ralph Fritsch
Sylvia Höller
Michael K. Kiessling
Markus Rechsteiner
Jan H. Rüschoff
Alessandra Curioni-Fontecedro

Frontiers in Oncology

doi 10.3389/fonc.2022.911294

5,991 views
21 citations

Correction

Published on 07 Jun 2022

Corrigendum: Selective Histone Deacetylase Inhibitor ACY-241 (Citarinostat) Plus Nivolumab in Advanced Non-Small Cell Lung Cancer: Results From a Phase Ib Study

in Thoracic Oncology

Mark M. Awad
Yvan Le Bruchec
Brian Lu
Jason Ye
Julie Ann Miller
Patrick H. Lizotte
Megan E. Cavanaugh
Amanda J. Rode
Calin Dan Dumitru
Alexander Spira

Frontiers in Oncology

doi 10.3389/fonc.2022.889996

1,916 views
1 citation

Original Research

Published on 07 Jun 2022

Continuous Vaginal Bleeding Induced By EGFR-TKI in Premenopausal Female Patients With EGFR Mutant NSCLC

in Thoracic Oncology

Min Yu
Xiaoyu Li
Xueqian Wu
Weiya Wang
Yanying Li
Yan Zhang
Shuang Zhang
Yongsheng Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.805538

4,434 views
5 citations

Systematic Review

Published on 07 Jun 2022

Efficacy of Osimertinib in EGFR-Mutated Advanced Non-small-Cell Lung Cancer With Different T790M Status Following Resistance to Prior EGFR-TKIs: A Systematic Review and Meta-analysis

in Thoracic Oncology

Xiao-Fang Yi
Jun Song
Ruo-Lin Gao
Li Sun
Zhi-Xuan Wu
Shu-Ling Zhang
Le-Tian Huang
Jie-Tao Ma
Cheng-Bo Han

Frontiers in Oncology

doi 10.3389/fonc.2022.863666

5,474 views
8 citations

Original Research

Published on 06 Jun 2022

Cost-Effectiveness of 12 First-Line Treatments for Patients With Advanced EGFR Mutated NSCLC in the United Kingdom and China

in Thoracic Oncology

Haijing Guan
Chunping Wang
Chen Chen
Sheng Han
Zhigang Zhao

Frontiers in Oncology

doi 10.3389/fonc.2022.819674

7,159 views
10 citations

Original Research

Published on 02 Jun 2022

A Pilot Study of Radiomics Models Combining Multi-Probe and Multi-Modality Images of 68Ga-NOTA-PRGD2 and 18F-FDG PET/CT for Differentiating Benign and Malignant Pulmonary Space-Occupying Lesions

in Thoracic Oncology

Fei Xie
Kun Zheng
Linwen Liu
Xiaona Jin
Lilan Fu
Zhaohui Zhu

Frontiers in Oncology

doi 10.3389/fonc.2022.877501

2,686 views
3 citations

Systematic Review

Published on 02 Jun 2022

Tumor Budding as a Marker for Poor Prognosis and Epithelial–Mesenchymal Transition in Lung Cancer: A Systematic Review and Meta-Analysis

in Thoracic Oncology

Nishant Thakur
Muhammad Joan Ailia
Yosep Chong
Ok Ran Shin
Kwangil Yim

Frontiers in Oncology

doi 10.3389/fonc.2022.828999

3,947 views
16 citations

Original Research

Published on 01 Jun 2022

Construction and Verification of Nomogram Model for Lung Adenocarcinoma With ≤ 5 Bone-Only Metastases Basing on Hematology Markers

in Thoracic Oncology

Chunliu Meng
Fang Wang
Minghong Chen
Hongyun Shi
Lujun Zhao
Ping Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.858634

2,502 views
2 citations

Original Research

Published on 01 Jun 2022

Identification and Validation of lncRNA-SNHG17 in Lung Adenocarcinoma: A Novel Prognostic and Diagnostic Indicator

in Thoracic Oncology

Xinyan Li
Yixiao Yuan
Mintu Pal
Xiulin Jiang

Frontiers in Oncology

doi 10.3389/fonc.2022.929655

4,493 views
7 citations

Original Research

Published on 31 May 2022

Impact of Introducing Intensity Modulated Radiotherapy on Curative Intent Radiotherapy and Survival for Lung Cancer

in Thoracic Oncology

Isabella Fornacon-Wood
Clara Chan
Neil Bayman
Kathryn Banfill
Joanna Coote
Alex Garbett
Margaret Harris
Andrew Hudson
Jason Kennedy
Laura Pemberton

Frontiers in Oncology

doi 10.3389/fonc.2022.835844

3,364 views
11 citations

Original Research

Published on 31 May 2022

Perioperative Outcomes of Video-Assisted Thoracoscopic Surgery Versus Open Thoracotomy After Neoadjuvant Chemoimmunotherapy in Resectable NSCLC

in Thoracic Oncology

Baihua Zhang
Qin Xiao
Haifan Xiao
Jie Wu
Desong Yang
Jinming Tang
Xu Li
Zhining Wu
Yong Zhou
Wenxiang Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.858189

4,816 views
26 citations

Original Research

Published on 31 May 2022

A Germline Mutation in ATR Is Associated With Lung Adenocarcinoma in Asian Patients

in Thoracic Oncology

Guangyao Bao
Xiaojiao Guan
Jie Liang
Yao Yao
Yifan Xiang
Tian Li
Xinwen Zhong

Frontiers in Oncology

doi 10.3389/fonc.2022.855305

4,804 views
6 citations

Original Research

Published on 30 May 2022

Combined Radiomic and Visual Assessment for Improved Detection of Lung Adenocarcinoma Invasiveness on Computed Tomography Scans: A Multi-Institutional Study

in Thoracic Oncology

Pranjal Vaidya
Kaustav Bera
Philip A. Linden
Amit Gupta
Prabhakar Shantha Rajiah
David R. Jones
Matthew Bott
Harvey Pass
Robert Gilkeson
Frank Jacono

Frontiers in Oncology

doi 10.3389/fonc.2022.902056

5,720 views
7 citations

Original Research

Published on 30 May 2022

Comprehensive Analysis of the Function, Immune Profiles, and Clinical Implication of m1A Regulators in Lung Adenocarcinoma

in Thoracic Oncology

Guangyao Bao
Tian Li
Xiaojiao Guan
Yao Yao
Jie Liang
Yifang Xiang
Xinwen Zhong

Frontiers in Oncology

doi 10.3389/fonc.2022.882292

2,907 views
13 citations

Original Research

Published on 30 May 2022

Identifying Immune Cell Infiltration and Effective Diagnostic Biomarkers in Lung Adenocarcinoma by Comprehensive Bioinformatics Analysis and In Vitro Study

in Thoracic Oncology

Xinyan Li
Xi Chen
Yixiao Yuan
RuiQing Zhai
William C. Cho
Xiulin Jiang

Frontiers in Oncology

doi 10.3389/fonc.2022.916947

3,328 views
7 citations

Mini Review

Published on 27 May 2022

Lung Cancer Treatment: From Tradition to Innovation

in Thoracic Oncology

Giuseppe Mangiameli
Ugo Cioffi
Alberto Testori

Frontiers in Oncology

doi 10.3389/fonc.2022.858242

5,683 views
24 citations

Case Report

Published on 26 May 2022

Long-Term Clinical Benefit in EGFR-Mutant Lung Adenocarcinoma With Local Squamous Cell Carcinoma Transformation After EGFR TKI Resistance: A Case Report

in Thoracic Oncology

Junru Ye
Yutong Ma
Qiuxiang Ou
Junrong Yan
Bin Ye
Yuping Li

Frontiers in Oncology

doi 10.3389/fonc.2022.883367

4,498 views
6 citations

1,967 articles

articles

Beyond Crizotinib: A Systematic Review and Meta-Analysis of the Next-Generation ALK Inhibitors as First-Line Treatment for ALK-Translocated Lung Cancer

Risk Factors for Brain Metastases in Patients With Small Cell Lung Cancer: A Systematic Review and Meta-Analysis

The Applicability of the Results in the Asian Population of ORIENT-11 to a Western Population According to the ICH-E5 Framework

Plasma CXCL14 as a Candidate Biomarker for the Diagnosis of Lung Cancer

Platelet Activation in High D-Dimer Plasma Plays a Role in Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Mutant Lung Adenocarcinoma

A Novel Score Combining Magnetic Resonance Spectroscopy Parameters and Systemic Immune-Inflammation Index Improves Prognosis Prediction in Non-Small Cell Lung Cancer Patients With Brain Metastases After Stereotactic Radiotherapy

Case Report: Exceptional Response to Poziotinib in Patient with Metastatic Non-Small Cell Lung Cancer With EGFR Exon 20 Insertion Mutation

Targeting ALK in Neuroendocrine Tumors of the Lung

Corrigendum: Selective Histone Deacetylase Inhibitor ACY-241 (Citarinostat) Plus Nivolumab in Advanced Non-Small Cell Lung Cancer: Results From a Phase Ib Study

Continuous Vaginal Bleeding Induced By EGFR-TKI in Premenopausal Female Patients With EGFR Mutant NSCLC

Efficacy of Osimertinib in EGFR-Mutated Advanced Non-small-Cell Lung Cancer With Different T790M Status Following Resistance to Prior EGFR-TKIs: A Systematic Review and Meta-analysis

Cost-Effectiveness of 12 First-Line Treatments for Patients With Advanced EGFR Mutated NSCLC in the United Kingdom and China

A Pilot Study of Radiomics Models Combining Multi-Probe and Multi-Modality Images of 68Ga-NOTA-PRGD2 and 18F-FDG PET/CT for Differentiating Benign and Malignant Pulmonary Space-Occupying Lesions

Tumor Budding as a Marker for Poor Prognosis and Epithelial–Mesenchymal Transition in Lung Cancer: A Systematic Review and Meta-Analysis

Construction and Verification of Nomogram Model for Lung Adenocarcinoma With ≤ 5 Bone-Only Metastases Basing on Hematology Markers

Identification and Validation of lncRNA-SNHG17 in Lung Adenocarcinoma: A Novel Prognostic and Diagnostic Indicator

Impact of Introducing Intensity Modulated Radiotherapy on Curative Intent Radiotherapy and Survival for Lung Cancer

Perioperative Outcomes of Video-Assisted Thoracoscopic Surgery Versus Open Thoracotomy After Neoadjuvant Chemoimmunotherapy in Resectable NSCLC

A Germline Mutation in ATR Is Associated With Lung Adenocarcinoma in Asian Patients

Combined Radiomic and Visual Assessment for Improved Detection of Lung Adenocarcinoma Invasiveness on Computed Tomography Scans: A Multi-Institutional Study

Comprehensive Analysis of the Function, Immune Profiles, and Clinical Implication of m1A Regulators in Lung Adenocarcinoma

Identifying Immune Cell Infiltration and Effective Diagnostic Biomarkers in Lung Adenocarcinoma by Comprehensive Bioinformatics Analysis and In Vitro Study

Lung Cancer Treatment: From Tradition to Innovation

Long-Term Clinical Benefit in EGFR-Mutant Lung Adenocarcinoma With Local Squamous Cell Carcinoma Transformation After EGFR TKI Resistance: A Case Report